(Date:12/2/2008).... 2 TYRX, Inc., a leader in the de...-device products, today announced the appointment ...esponsible for commercial operations. , , M...e medical device industry. Mr. Elliot joins TYRX f...on providing laser-based antimicrobial and vascula...
(Date:12/2/2008)...-- Services form an integral part of most of,orig... has therefore become,essential for service provi...ket to remain competitive and constantly improve t... (Logo: http://www.newscom.com/cgi-bin/prnh...t & Sullivan ( http://www.medicalimaging.frost...
(Date:12/2/2008)...na Health and Solutions Medical Billing Team Up To...s in a Cloud" as a SaaS Application. , ...mber 2, 2008 -- Making medical insurance claims is...st phase of a "Claims in a Cloud" softwa...delling partners Xena Health and Solutions Medical...
(Date:12/2/2008)...es your over-the-phone interpretation vendor conti...ompleted the call? , Wash...rld of over-the-phone interpretation (OPI), every ...r one minute can add up over the course of a billi...anization employs an over-the-phone interpretation...
Breaking Medicine News(10 mins):Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 3Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3Health News:Corporate Modelling Partners Start Selling BPM in Cloud Service 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 2Health News:Be Aware: Over-the-Phone Interpretation Billing Methods Vary Widely 3(Date:12/1/2008)...Prox1 gene is a two-way switch that, if turned off...ammed so that they lose their identity and become ...IS, Tenn., Dec. 1 Scie...ve discovered that a certain differentiated cell t...uires the constant expression of a gene called Pr...
(Date:12/1/2008)...ecember 1 Following a,R... to procure an MVA-based,third generation smallp...Canada, on behalf of the Canadian Department of Na...n Nordic for the delivery of IMVAMUNE(R). , ...) as part of the,country,s bio-preparedness progr...
(Date:12/1/2008)...wire-FirstCall/ -- Vical Incorporated (Nasdaq: V...n milestone payment from Merck & Co., Inc. bas...ical trial of an investigational plasmid DNA (pDNA...n Vical,s DNA gene delivery technology and encodes...TERT is the subject of separate license agreement....
(Date:11/28/2008)...vember 28 German biotech company,...alized HIV monitoring and,AIDS patient follow-up ... In,the year 2008, 2.5 million patient tests have...hly affordable "CyFlow" system, supporting already... Due to introduction of the,Partec innovation, th...
Breaking Medicine Technology:Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 1Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 2Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis 2570 3Death Rates for HIV Patients Decrease Dramatically 23075 1Death Rates for HIV Patients Decrease Dramatically 23075 2Death Rates for HIV Patients Decrease Dramatically 23075 3Best treatment for MS may depend on disease subtype 23072 1Best treatment for MS may depend on disease subtype 23072 2Best treatment for MS may depend on disease subtype 23072 3The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 1The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 2The Parkinsons Disease Foundation awards 24950 000 in seed grants 3849 3...S WIRE)--Mar 22, 2007 - Nutra Pharma,Corp. (OTCBB:...,drugs for HIV and Multiple Sclerosis has today an...harm, has received notification of,acceptance of i...n,Immunology special conference issue., The articl...y,for Multiple Sclerosis; a review of the literatu...
...aplatin Demonstrated Statistically,Significant Imp...BERLIN, March 22, 2007 /PRNewswire-FirstCall/ -- P...nced additional data from,the double-blind, random... SPARC trial (Satraplatin and Prednisone Against,R...e 22nd Annual,European Association of Urology Cong...
Other Medicine Technology:Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 2Nutra Pharma Announces Publication of Research on Treatment for,Multiple Sclerosis 3Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 2Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 3Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 4Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 5Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 6Additional Data From Satraplatin SPARC Phase 3 Trial Presented at,European Association of Urology Congress 7Measles IgG ELISA test system is designed for the qualitative detection of IgG antibodies to Measles (Rubeola) virus in human serum, and is for in vitro diagnostic use.
Inquire
... Enzymelinked Immunosorbent Assays(ELISA) is inten...on of IgG antibody to Measles Rubeola) virus in hu...or the determination of immune status. Paired sera...rate seroconversion or a significant rise in antib...
The DSL-05-01-MEM Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Measles virus in human serum. This assay is intended fo
Medicine Products: